Here is a list of additional organizations for more information and assistance in the treatment of Hodgkin's Lymphoma.

American Cancer Society

www.cancer.org
(800) 227-2345

Association of Cancer Online Resources

www.acor.org
(212) 226-5525

The Leukemia & Lymphoma Society

www.leukemia.org
(800) 955-4572

Lymphoma Research Foundation

www.lymphoma.org
(800) 500-9976

National Cancer Institute

www.cancer.gov
(800) 4-CANCER

National Organization for Rare Disorders (NORD)

www.rarediseases.org
(800) 999-6673

SuperSibs!

www.supersibs.org
(847)-705-7427
Toll Free (886)-444-7427

The Ulman Cancer Fund for Young Adults

www.ulmanfund.org
(888) 393-FUND

Back To Top

Important Safety Information

WARNING
It is recommended that MATULANE be given only by or under the supervision of a physician experienced in the use of potent antineoplastic drugs. Adequate clinical and laboratory facilities should be available to patients for proper monitoring of treatment.

Matulane is contraindicated in patients with known hypersensitivity to the drug or inadequate marrow reserve as demonstrated by bone marrow aspiration. Due consideration of this possible state should be given to each patient who has leukopenia, thrombocytopenia, or anemia.

Matulane in combination therapy is a potent chemotherapeutic agent. Before prescribing Matulane, the sections in the Prescribing Information concerning usage in pregnancy, occurrence of secondary cancers, monitoring required in liver and kidney disease, hematologic effects, CNS effects, and potentiation associated with alcohol and MAO inhibitors should be carefully evaluated.

Please see full Prescribing Information for Matulane indications and usage, contraindications, and warnings including boxed WARNINGS, precautions, and adverse reactions.